Efficacy and Tolerability Study of V501 in Japanese Males (V501-122)
Clinical trial NCT01862874 · COMPLETED
Trial details
- NCT number
- NCT01862874
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-27
- Primary completion
- 2017-08-30
- Enrollment
- 1124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.